LIMINATUS PHARMA, INC.
LIMINATUS PHARMA, INC. is a registered legal entity registered in United States under 7710103, and its current status with Delaware Division of Corporations is active. The company was incorporated on 11 June 2020 and lists its registered address as United States. 5 shareholders are on record for LIMINATUS PHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for LIMINATUS PHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Clear Street Group Inc., holding 29.4% — the largest recorded stake — followed by Aristeia Capital, LLC at 11.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 13 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Clear Street Group Inc. | 29.4% | Delaware Division of Corporations | |
| Aristeia Capital, LLC | 11.7% | Delaware Division of Corporations | |
| Linden Advisors LP | 9.8% | Delaware Division of Corporations | |
| Saba Capital Management, L.P. | 8.5% | Delaware Division of Corporations | |
| UBS Group AG | 5.6% | Delaware Division of Corporations |
Officers
5
The Ceo & Chairman of LIMINATUS PHARMA, INC. currently on record is Chris Kim J.d., L.l.m.; five officers are currently on record for LIMINATUS PHARMA, INC., filed with Delaware Division of Corporations.
Management authority at LIMINATUS PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
LIMINATUS PHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
LIMINATUS PHARMA, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns LIMINATUS PHARMA, INC.?
Five shareholders are currently on record for LIMINATUS PHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Clear Street Group Inc., holding 29.4% — the largest recorded stake — followed by Aristeia Capital, LLC at 11.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is LIMINATUS PHARMA, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for LIMINATUS PHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does LIMINATUS PHARMA, INC. have on record?
5 shareholders are shown on record for LIMINATUS PHARMA, INC.. The register reports 13 in total; only the top 5 by holding are shown here.
What is LIMINATUS PHARMA, INC.'s company registration number?
LIMINATUS PHARMA, INC.'s registration number is 7710103, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is LIMINATUS PHARMA, INC. still an active company?
LIMINATUS PHARMA, INC.'s status on Delaware Division of Corporations is listed as active.
When was LIMINATUS PHARMA, INC. incorporated?
LIMINATUS PHARMA, INC. was incorporated on 11 June 2020, according to Delaware Division of Corporations.
What is LIMINATUS PHARMA, INC.'s registered address?
The registered address on file for LIMINATUS PHARMA, INC. is United States.
Who are the officers/directors of LIMINATUS PHARMA, INC.?
The Ceo & Chairman of LIMINATUS PHARMA, INC. currently on record is Chris Kim J.d., L.l.m.; five officers are currently on record for LIMINATUS PHARMA, INC., filed with Delaware Division of Corporations. Management authority at LIMINATUS PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does LIMINATUS PHARMA, INC. have a parent company or subsidiaries?
LIMINATUS PHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to LIMINATUS PHARMA, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to LIMINATUS PHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access LIMINATUS PHARMA, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like LIMINATUS PHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 5 October 2026.